TrialArthritis research & therapy2006

Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus.

Thomas Dörner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.